Moreover, elevated beta-2-microglobulin (B2M) plasma levels account for two CLL-IPI scoring points, frequently upgrading patients to a higher risk group for inferior OS. The gene discussed is B2M; the disease is B-cell chronic lymphocytic leukemia.